Dr. Rob Riley is a highly motivated, seasoned science, project, and people leader, and proven drug hunter with >30 years experience in Biopharmaceutical Research & Development in the major therapeutic areas. A pharmacologist by training with a keen eye for compound properties and quality, Rob oversaw the delivery of many meaningful medicines, including Kengreal and Brilinta, while in pharma (Fisons, Astra, Astrazeneca; ~25 years) as Head of DMPK and Chemistry. He recently served as Head of Worldwide DMPK at Evotec and Head of Cyprotex.